Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2019 | Immune reconstitution after HLA-HSCT

Leonido Luznik • 26 Oct 2019
COSTEM 2019
General

Leo Luznik, MD, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MA, discusses immune reconstitution after T-cell replete HLA-haploidentical transplantation (HLA-HSCT) at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

More from Leonido Luznik

Prevention strategies for acute and chronic GVHD in patients who have undergone transplantation
1:18
Prevention strategies for acute and chronic GVHD in patients who have undergone transplantation
Leonido Luznik • 21 Oct 2023
The role of PTCy/MMF/CNI as the standard of care for GvHD prophylaxis in the MUD setting
2:03
The role of PTCy/MMF/CNI as the standard of care for GvHD prophylaxis in the MUD setting
Leonido Luznik • 21 Oct 2023
Promising strategies to prevent GvHD in high-risk patients
1:13
Promising strategies to prevent GvHD in high-risk patients
Leonido Luznik • 21 Oct 2023
Donor type and source of choice
1:55
Donor type and source of choice
Leonido Luznik • 26 Oct 2019

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals